Skip to main content

Advertisement

Table 3 Outcomes of anti-Jo1 patients with antisynthetase syndrome a

From: Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome

Outcomes Data, n(%)
Resolution 13 (15.1%)
Improvement 55 (63.9%)
Deterioration 18 (20.9%)
ASS course  
 Monocyclic 1 (1.2%)
 Chronic continuous 56 (65.1%)
Recurrences  
 During tapering of high-dose steroids 5 (5.8%)
 During tapering of low-dose steroids 69 (80.2%)
 Off treatment 1 (1.2%)
 Mortality 10 (11.6%)
  1. aASS: antisynthetase syndrome.